Abstract
New findings (Krishnamurty et al.) implicate a subset of cancer-associated fibroblasts (CAFs) that express leucine-rich repeat containing 15 (LRRC15) in promoting tumor growth in pancreatic adenocarcinoma (PDAC), by suppressing the antitumor immunity of cytotoxic T cells. Genetic ablation of LRRC15+ CAFs resulted in better response to immune checkpoint blockade, suggesting they may be a novel target for therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1-2 |
| Number of pages | 2 |
| Journal | TRENDS IN CANCER |
| Volume | 9 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CAFs
- LRRC15
- PDAC
- immune suppression
- microenvironment
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'myCAFs are better than yours: targeting myofibroblasts potentiates immunotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver